The prevalence of concurrent cancer and severe aortic stenosis (AS) is increasing due to an
ageing population. In addition to shared traditional risk factors for AS and cancer, patients …

El tratamiento de la estenosis aórtica se inicia en 1960 con el primer reemplazo valvular
usando una prótesis de bola. El desarrollo posterior de la cirugía cardíaca masifica el …

OBJECTIVES Full sternotomy (FS) is the common surgical access for patients undergoing
open aortic valve replacement (AVR) with concomitant supracommissural replacement of …

Background Transcatheter aortic valve replacement (TAVR) has evolved as an alternative to
surgical aortic valve replacement (SAVR). In addition to full-sternotomy (FS), recent reports …

The landscape of aortic valve replacement (AVR) has evolved dramatically over the years,
but time-varying outcomes have yet to be comprehensively explored. This study aimed to …

Background Large bore percutaneous access is becoming increasingly common. Parallel to
this, we observe an increase in vascular access site complications such as bleeding …

The publication of the 2020 ACC/AHA guidelines for the management of patients with heart
valve disease, while updating essential steps for clinical evaluation and diagnosis, and …

The introduction of transcatheter aortic valve replacement (TAVR) just two decades ago has
transformed the treatment of severe symptomatic aortic stenosis. TAVR has not only …

Objective: Transcatheter aortic valve replacement (TAVR) has arisen as a viable alternative
to surgery. Similarly, minimally invasive surgical aortic valve replacement (mini-SAVR), such …

Background Although transfemoral transcatheter aortic valve implantation (TF-TAVI) offers
superior early outcome over open surgical aortic valve replacement (SAVR) in the elderly, a …